Patents Assigned to 4D Pharma Research Limited
  • Compositions comprising bacterial strains
    Patent number: 10058574
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Grant
    Filed: May 10, 2017
    Date of Patent: August 28, 2018
    Assignee: 4D Pharma Research Limited
    Inventors: George Grant, Angela Margaret Patterson, Imke Mulder, Seanin McCluskey, Emma Raftis
  • Compositions comprising bacterial strains
    Patent number: 10046015
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: August 14, 2018
    Assignee: 4D Pharma Research Limited
    Inventors: Imke Elisabeth Mulder, Amy Beth Holt, Seanin Marie McCluskey, Grainne Clare Lennon, Suaad Ahmed
  • Compositions comprising bacterial strains
    Patent number: 9987311
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: June 5, 2018
    Assignee: 4D Pharma Research Limited
    Inventors: Imke Elisabeth Mulder, Amy Beth Holt, Seanin Marie McCluskey, Grainne Clare Lennon, Suaad Ahmed
  • Compositions comprising bacterial strains
    Patent number: 9974815
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing cancer.
    Type: Grant
    Filed: November 3, 2017
    Date of Patent: May 22, 2018
    Assignee: 4D Pharma Research Limited
    Inventors: Imke Elisabeth Mulder, Amy Beth Holt, Domenico Panzica, Seanin Marie McClusky
  • Composition of
    Patent number: 9937211
    Abstract: A first aspect of the invention relates to the bacterial species Roseburia hominis for use in: regulating the immune system of a subject treating an immune disorder; treating an intestinal disorder; improving intestinal microbiota; regulating the innate immune system of a subject; regulating the adaptive immune system of a subject; regulating appetite in a subject; promoting Tregs and immune tolerance; promoting gut health in a subject; and/or maintaining immune homeostasis in a subject. Further aspects of the invention relate to compositions comprising Roseburia hominis.
    Type: Grant
    Filed: March 15, 2016
    Date of Patent: April 10, 2018
    Assignee: 4D Pharma Research Limited
    Inventors: Denise Kelly, Imke Mulder
  • Compositions comprising bacterial strains
    Patent number: 9839655
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing cancer.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: December 12, 2017
    Assignee: 4D Pharma Research Limited
    Inventors: Imke Elisabeth Mulder, Amy Beth Holt, Domenico Panzica, Seanin Marie McCluskey
  • Polypeptide and immune modulation
    Patent number: 9796762
    Abstract: The present invention relates to Roseburia flagellin, and/or a polynucleotide sequence encoding said Roseburia flagellin, and/or a vector comprising said polynucleotide sequence, and/or a host cell, including bacteria, comprising said vector, and/or a host cell, including bacteria, comprising said polynucleotide sequence, for use in modulating the inflammation of a tissue or an organ in a subject.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: October 24, 2017
    Assignee: 4D Pharma Research Limited
    Inventors: Denise Kelly, Angela Patterson, Edouard Monnais, Imke Mulder
  • Porcine lactic acid bacterial strains
    Patent number: 9539293
    Abstract: Described herein are porcine lactic acid bacterial strain compositions and processes of obtaining porcine lactic acid bacterial strains. Further aspects of the invention relate to food additives, supplements and probiotic compositions comprising said bacterial strains, and therapeutic uses of said bacterial strain compositions.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: January 10, 2017
    Assignee: 4D Pharma Research Limited
    Inventor: Denise Kelly
  • Bacterium for use as a probiotic for nutritional and medical applications
    Patent number: 9314489
    Abstract: A first aspect of the invention relates to the bacterial species Roseburia hominis for use in: regulating the immune system of a subject treating an immune disorder; treating an intestinal disorder; improving intestinal microbiota; regulating the innate immune system of a subject; regulating the adaptive immune system of a subject; regulating appetite in a subject; promoting Tregs and immune tolerance; promoting gut health in a subject; and/or maintaining immune homeostasis in a subject. Further aspects of the invention relate to compositions comprising Roseburia hominis.
    Type: Grant
    Filed: October 8, 2012
    Date of Patent: April 19, 2016
    Assignee: 4D Pharma Research Limited
    Inventors: Denise Kelly, Imke Mulder